PDS Biotechnology Corp Head And Neck Cancer KOL Roundtable Transcript
Greetings, and welcome to the PDS Biotech head and neck cancer KOL roundtable. (Operator Instructions) As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Dr. Lauren V. Wood, Chief Medical Officer for PDS Biotech. Dr. Wood, please proceed.
Good morning, everyone, and welcome to PDS Biotech's head and neck cancer KOL roundtable webcast. With me today are Dr. Neil Gross from the University of Texas, MD Anderson Cancer Center; Dr. Katharine Price from the Mayo Clinic Comprehensive Cancer Center; and Dr. Jared Weiss from the UNC Lineberger Cancer Center.
I will provide formal introductions in a moment, but before we begin, I would like to caution listeners that comments made during this webcast may include forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve material risks and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |